Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data

Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data

BackgroundThe aim of this meta-analysis was to ascertain whether sotrovimab was effective in reducing COVID-19 related hospitalization and mortality also in Omicron BA.2, BA.4 and BA.5 subvariants compared to other antivirals effective in index period.MethodsA systematic review and meta-analysis of...

Full description

Bibliographic Details
Main Authors: Antonio Russo, Pierantonio Grimaldi, Mariantonietta Pisaturo, Lorenzo Onorato, Nicola Coppola
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
COVID-19
monoclonal antibodies
early treatment
mortality
hospitalization
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1295029/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1295029/full

Similar Items